Cargando…
Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region
Splenic marginal zone lymphoma (SMZL) is a rare indolent B-cell neoplasm with hepatitis virus supposed to involve in the pathogenesis. The characteristics of SMZL derived from Caucasia population and high hepatitis C virus (HCV) infection region have been widely investigated, but few was reported in...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716765/ https://www.ncbi.nlm.nih.gov/pubmed/29228725 http://dx.doi.org/10.18632/oncotarget.21931 |
_version_ | 1783284019831504896 |
---|---|
author | Yi, Shuhua Yan, Yuting Xiong, Wenjie Lv, Rui Yu, Zhen Liu, Wei Liu, Enbin Li, Heng Liu, Huimin Li, Zengjun An, Gang Xu, Yan Ru, Kun Zou, Dehui Qiu, Lugui |
author_facet | Yi, Shuhua Yan, Yuting Xiong, Wenjie Lv, Rui Yu, Zhen Liu, Wei Liu, Enbin Li, Heng Liu, Huimin Li, Zengjun An, Gang Xu, Yan Ru, Kun Zou, Dehui Qiu, Lugui |
author_sort | Yi, Shuhua |
collection | PubMed |
description | Splenic marginal zone lymphoma (SMZL) is a rare indolent B-cell neoplasm with hepatitis virus supposed to involve in the pathogenesis. The characteristics of SMZL derived from Caucasia population and high hepatitis C virus (HCV) infection region have been widely investigated, but few was reported in the Eastern population with HBV prevalent region. We analyzed the clinical characteristics, cytogenetic aberrations and prognostic factors in 160 SMZL patients from China. 25 patients (16%) were HBsAg-positive and 54 (34%) patients with resolved HBV infection. IGH gene usage was analyzed in 39 patients. The preferential usages of IGHV genes were IGHV1-2 (26%), followed by IGHV4-34 (18%) and IGHV2-70 (10%). The patients with HBV infection presented biased IGHV-D-J rearrangements and mutational status. Using three independent factors hemoglobin level, HBsAg positivity and complex karyotype, we developed a new hierarchical prognostic model, which showed a better c-index than the previously reported IIL and HPLL scoring systems in SMZL. In conclusion, SMZL in HBV prevalent region have unique clinical and biological characteristics and new prognostic scoring model should be adopted in this population. |
format | Online Article Text |
id | pubmed-5716765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57167652017-12-08 Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region Yi, Shuhua Yan, Yuting Xiong, Wenjie Lv, Rui Yu, Zhen Liu, Wei Liu, Enbin Li, Heng Liu, Huimin Li, Zengjun An, Gang Xu, Yan Ru, Kun Zou, Dehui Qiu, Lugui Oncotarget Research Paper Splenic marginal zone lymphoma (SMZL) is a rare indolent B-cell neoplasm with hepatitis virus supposed to involve in the pathogenesis. The characteristics of SMZL derived from Caucasia population and high hepatitis C virus (HCV) infection region have been widely investigated, but few was reported in the Eastern population with HBV prevalent region. We analyzed the clinical characteristics, cytogenetic aberrations and prognostic factors in 160 SMZL patients from China. 25 patients (16%) were HBsAg-positive and 54 (34%) patients with resolved HBV infection. IGH gene usage was analyzed in 39 patients. The preferential usages of IGHV genes were IGHV1-2 (26%), followed by IGHV4-34 (18%) and IGHV2-70 (10%). The patients with HBV infection presented biased IGHV-D-J rearrangements and mutational status. Using three independent factors hemoglobin level, HBsAg positivity and complex karyotype, we developed a new hierarchical prognostic model, which showed a better c-index than the previously reported IIL and HPLL scoring systems in SMZL. In conclusion, SMZL in HBV prevalent region have unique clinical and biological characteristics and new prognostic scoring model should be adopted in this population. Impact Journals LLC 2017-10-19 /pmc/articles/PMC5716765/ /pubmed/29228725 http://dx.doi.org/10.18632/oncotarget.21931 Text en Copyright: © 2017 Yi et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Yi, Shuhua Yan, Yuting Xiong, Wenjie Lv, Rui Yu, Zhen Liu, Wei Liu, Enbin Li, Heng Liu, Huimin Li, Zengjun An, Gang Xu, Yan Ru, Kun Zou, Dehui Qiu, Lugui Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title | Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title_full | Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title_fullStr | Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title_full_unstemmed | Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title_short | Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region |
title_sort | distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in hbv high prevalent region |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716765/ https://www.ncbi.nlm.nih.gov/pubmed/29228725 http://dx.doi.org/10.18632/oncotarget.21931 |
work_keys_str_mv | AT yishuhua distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT yanyuting distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT xiongwenjie distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT lvrui distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT yuzhen distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT liuwei distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT liuenbin distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT liheng distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT liuhuimin distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT lizengjun distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT angang distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT xuyan distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT rukun distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT zoudehui distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion AT qiulugui distinctclinicalcharacteristicsdrawanewprognosticmodelforsplenicmarginalzonelymphomainhbvhighprevalentregion |